Issue 33, 2019

Dual-action organoplatinum polymeric nanoparticles overcoming drug resistance in ovarian cancer

Abstract

Drug resistance to the conventional platinum chemotherapy remains a major challenge for treating ovarian cancer. Herein, we present a novel approach to overcome the drug resistance by utilizing “dual-action” organometallic polymeric nanoparticles (OPNPs). The OPNPs were formed by the assembly of the organoplatinum payloads and the anionic block copolymer, methoxy polyethylene glycol-block-polyglutamic acid (MPEG5k-PGA50). The OPNPs enhance the solubility and biocompatibility of the hydrophobic organoplatinum payloads. The OPNPs enter the cancer cells via endocytosis, and the payloads loaded in the core of the nanoparticles are slowly released under the acidic conditions of endosomes. Unlike conventional platinum therapeutics, the organoplatinum compound exhibits a “dual-action” attack by triggering nuclear DNA damage and mitochondrial damage. As a result, drug-resistant ovarian cancer cells become vulnerable to the organoplatinum payloads.

Graphical abstract: Dual-action organoplatinum polymeric nanoparticles overcoming drug resistance in ovarian cancer

Supplementary files

Article information

Article type
Paper
Submitted
22 Apr 2019
Accepted
10 Jul 2019
First published
10 Jul 2019

Dalton Trans., 2019,48, 12451-12458

Author version available

Dual-action organoplatinum polymeric nanoparticles overcoming drug resistance in ovarian cancer

A. M. D. S. Jayawardhana, Z. Qiu, S. Kempf, H. Wang, M. Miterko, D. J. Bowers and Y. Zheng, Dalton Trans., 2019, 48, 12451 DOI: 10.1039/C9DT01683J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements